Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Common Shares in the Capital of CRH Medical Corporation

TORONTO, ONTARIO--(Marketwired - Jan. 7, 2014) - Fernbank LLC ("Fernbank") announces that following a set of transactions ending on January 6, 2014 which were conducted through the facilities of the Toronto Stock Exchange, it acquired 108,900 common shares (the "Acquisition") of CRH Medical Corporation ("CRH" or the "Corporation"). Immediately following the Acquisition, Fernbank owned, controlled and had direction over an aggregate of 4,905,900 common shares of the Corporation on a non-diluted basis, representing approximately 10.1% of CRH's outstanding common shares at that time.

Fernbank acquired the common shares for investment purposes only and it may, in the future, depending on market and other conditions, increase or decrease its beneficial ownership, control or direction over Common Shares in the capital of the Corporation.

A copy of the early warning report filed in connection with this press release may be found on www.sedar.com under CRH's corporate profile page.